Stay updated on Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.

Latest updates to the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page
- Check2 days agoChange DetectedThe Revision: v3.6.5 label is now shown, replacing the previous Revision: v3.6.4. This indicates a new build deployment without altering the study information or page functionality.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision tag 'Revision: v3.6.4' appears, replacing 'Revision: v3.6.3', signaling a minor platform update without changes to content or user-facing features.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page footer now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a minor platform update without changes to the study content or user-facing details.SummaryDifference0.0%

- Check45 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, signaling a new version of the page. This reflects a version-control update rather than a substantive change to the study details.SummaryDifference0.0%

- Check59 days agoChange DetectedThe study page now indicates recruitment has ended with 'No longer looking for participants' and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment label formatting was adjusted (from 'Intervention / Treatment') and a revision note shows as v3.6.0.SummaryDifference0.2%

- Check67 days agoChange DetectedThe page now displays a new revision tag 'Revision: v3.5.5', replacing the previous 'Revision: v3.5.4'. This is a metadata update indicating a new edition of the study record without altering its substantive content.SummaryDifference0.0%

Stay in the know with updates to Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.